Company Name, Ticker, Competitors, else..

Eloxx Pharmaceuticals Inc (NASDAQ: ELOX)

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Eloxx Pharmaceuticals Inc 's

Name: Eloxx Pharmaceuticals Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ELOX Sales vs. its Competitors Q1 2026

Comparing the current results to its competitors, Eloxx Pharmaceuticals Inc reported Revenue increase in the 1 quarter 2026 by 0 % year on year, while most of its competitors have experienced contraction in revenues by -2.77 %, achieved in the same quarter.

• List of ELOX Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Eloxx Pharmaceuticals Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 34.37 %

<< ELOX Stock Performance Comparisons

<< See the full list of ELOX competitors

*Market share is calculated based on total revenue.

ELOX's Stock Performance relative to its Competitors

Publicly Traded Peers of Eloxx Pharmaceuticals Inc

Meiragtx Holdings Plc
Share Performance

-5.95%

This Quarter

Meiragtx Holdings Plc

Profile

MeiraGTx Holdings Plc is a biotechnology company focused on developing gene therapies for inherited and acquired diseases. They leverage their proprietary technology to develop and commercialize innovative treatments that address unmet medical needs.

More about Meiragtx Holdings Plc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,023.416 mill.	$ 397.501 mill.	$ 78.931 mill.

Sarepta Therapeutics Inc
Share Performance

-12.39%

This Year

Sarepta Therapeutics Inc

Profile

Sarepta Therapeutics Inc's business model centers around the research, development, and commercialization of innovative genetic medicines for rare diseases, with a particular focus on Duchenne muscular dystrophy (DMD).

More about Sarepta Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,968.397 mill.	$ 1,974.344 mill.	$ -136.725 mill.

Ultragenyx Pharmaceutical Inc
Share Performance

-0.07%

Over The Past 5 Days

Ultragenyx Pharmaceutical Inc

Profile

Ultragenyx Pharmaceutical Inc's business model focuses on developing and commercializing innovative therapies for rare genetic diseases.

More about Ultragenyx Pharmaceutical Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,477.550 mill.	$ 717.212 mill.	$ -585.969 mill.

Ptc Therapeutics inc
Share Performance

-18.33%

This Year

Ptc Therapeutics inc

Profile

PTC Therapeutics Inc's business model revolves around the research, development, and commercialization of innovative treatments for rare and genetic diseases.

More about Ptc Therapeutics inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 5,766.894 mill.	$ 1,008.754 mill.	$ -37.423 mill.

Biomx Inc
Share Performance

+415.33%

30 Days

Biomx Inc

Profile

The company develops phage-based therapies aimed at targeting harmful bacteria responsible for chronic diseases.

More about Biomx Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.728 mill.	$ 0.332 mill.	$ -34.601 mill.

11 more competitors available

Sources: Eloxx Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 26, 2026 7:35 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Eloxx Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.